We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$30.4B
AUM Growth
+$3.48B
(+13%)
Cap. Flow
+$841M
Cap. Flow
% of AUM
2.77%
Top 10 Holdings %
Top 10 Hldgs %
10.11%
Holding
1,992
New
240
Increased
827
Reduced
644
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$151M |
| 2 |
Applied Materials
AMAT
|
+$145M |
| 3 |
Intuit
INTU
|
+$142M |
| 4 |
Humana
HUM
|
+$115M |
| 5 |
Sherwin-Williams
SHW
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expedia Group
EXPE
|
+$177M |
| 2 |
Exelon
EXC
|
+$128M |
| 3 |
NXP Semiconductors
NXPI
|
+$124M |
| 4 |
UnitedHealth
UNH
|
+$119M |
| 5 |
PayPal
PYPL
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.39% |
| 2 | Healthcare | 14.41% |
| 3 | Financials | 14.4% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Alnylam Pharmaceuticals
ALNY
$36.3B
| $370K | ﹤0.01% |
3,215
-8,255
| -72% | -$823K |
|
|
LVGO
1577
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $370K | ﹤0.01% |
14,782
-4,743
| -24% | -$113K |
|
1578
Cato Corp
CATO
$65.9M
| $368K | ﹤0.01% |
21,144
-22,700
| -52% | -$406K |
|
1579
Enerpac Tool Group
EPAC
$1.77B
| $368K | ﹤0.01% |
+14,112
| New | +$345K |
|
1580
Rush Enterprises Class A
RUSHA
$5.95B
| $350K | ﹤0.01% |
16,967
-45,117
| -73% | -$878K |
|
|
ENDP
1581
DELISTED
Endo International plc
ENDP
| $348K | ﹤0.01% |
74,150
+62,130
| +517% | +$277K |
|
1582
James River Group Holdings
JRVR
$218M
| $344K | ﹤0.01% |
8,355
-1,351
| -14% | -$53.1K |
|
1583
Core Laboratories
CLB
$538M
| $342K | ﹤0.01% |
+9,080
| New | +$408K |
|
1584
DexCom
DXCM
$27.6B
| $342K | ﹤0.01% |
6,260
-160
| -2% | -$7.59K |
|
|
HOUS
1585
DELISTED
Anywhere Real Estate
HOUS
| $341K | ﹤0.01% |
+35,248
| New | +$323K |
|
1586
Agios Pharmaceuticals
AGIO
$2.16B
| $337K | ﹤0.01% |
7,065
-21,954
| -76% | -$830K |
|
1587
Floor & Decor
FND
$5.81B
| $337K | ﹤0.01% |
6,629
-3,200
| -33% | -$150K |
|
|
STAY
1588
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $337K | ﹤0.01% |
22,700
-173,437
| -88% | -$2.53M |
|
|
GNMK
1589
DELISTED
GenMark Diagnostics, Inc
GNMK
| $337K | ﹤0.01% |
70,054
-25,200
| -26% | -$139K |
|
1590
M/I Homes
MHO
$3.83B
| $335K | ﹤0.01% |
+8,508
| New | +$356K |
|
1591
Safety Insurance
SAFT
$1.52B
| $333K | ﹤0.01% |
3,601
-1,182
| -25% | -$115K |
|
|
KNL
1592
DELISTED
Knoll, Inc.
KNL
| $332K | ﹤0.01% |
13,160
+5,012
| +62% | +$132K |
|
|
EBIX
1593
DELISTED
Ebix Inc
EBIX
| $331K | ﹤0.01% |
9,934
+2,204
| +29% | +$81.4K |
|
|
SGMO
1594
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $326K | ﹤0.01% |
38,949
| – | – |
|
1595
APA Corp
APA
$12.8B
| $323K | ﹤0.01% |
12,623
-184,192
| -94% | -$4.17M |
|
1596
Perdoceo Education
PRDO
$1.9B
| $323K | ﹤0.01% |
17,567
-16,544
| -49% | -$269K |
|
1597
Northwest Bancshares
NWBI
$2.25B
| $322K | ﹤0.01% |
19,388
-175,043
| -90% | -$2.93M |
|
|
MR
1598
DELISTED
Montage Resources Corporation Common Stock
MR
| $321K | ﹤0.01% |
+40,430
| New | +$211K |
|
1599
FirstCash
FCFS
$8.55B
| $320K | ﹤0.01% |
3,969
-656
| -14% | -$55.1K |
|
1600
Jones Lang LaSalle
JLL
$15.1B
| $319K | ﹤0.01% |
1,834
-13,334
| -88% | -$2.1M |
|
Similar funds
Man Group's Q4 2019 Portfolio in Review
As of Q4 2019, Man Group held 1,992 positions worth $30.4B, up 13% from $26.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Man Group's Q4 2019 filing shows 240 new, 827 increased, 644 reduced and 177 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 1,207,475 shares worth $54.2M. The largest sale was Expedia Group, an estimated $177M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Man Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 1,207,475 shares worth $54.2M.
- Man Group added most to Procter & Gamble in Q4 2019, an estimated $151M increase.
- Man Group's biggest Q4 2019 reduction was Expedia Group, cutting an estimated $177M.
- Man Group fully exited Celgene Corp in Q4 2019, selling an estimated $47.9M.
- Man Group's ten largest holdings make up 10% of its $30.4B portfolio in Q4 2019.
- Man Group opened 240 new positions and closed 177 in Q4 2019.
- Man Group's portfolio value rose 13% quarter-over-quarter to $30.4B.
Based on Man Group's 13F filing for Q4 2019, filed 18 Feb 2020.